CD1a/HTA1 (Mature Langerhans Cells Marker) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-CD1a/HTA1 (Mature Langerhans Cells Marker) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD1a/HTA1 (Mature Langerhans Cells Marker) |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | purified |
| Size | 0.02 mg (With BSA & Azide at 0.2mg/ml), 0.1 mg (With BSA & Azide at 0.2mg/ml), 0.1 mg (Without BSA & Azide at 1mg/ml) |
| Concentration | n/a |
| Applications | Immunohistochemistry (IHC) Paraffin |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic l |
| Immunogen | Immunogen: Recombinant human CD1a protein |
| Other Names | [Cortical thymocyte antigen CD1A; Epidermal dendritic cell marker CD1a; FCB6; HTA1; T cell surface antigen T6/Leu 6; T-Cell Surface Glycoprotein CD1A] |
| Gene, Accession # | [CD1A], Gene ID: 909, NCBI: P06126.4, UniProt: P06126 |
| Catalog # | MBS4381376 |
| Price | $190, $340, $340 |
| Order / More Info | CD1a/HTA1 (Mature Langerhans Cells Marker) Antibody from MYBIOSOURCE INC. |
| Product Specific References | 1. Cassaday, RD. et al. 2007. Clin. Cancer Res. 13: 540-549. 2. Matsuda, A. et al. 2009. Invest. Ophthalmol. Vis. Sci. 50: 2871-2877. 3. Gulubova, M. et al. 2008. Clin. Exp. Metastasis. 25: 777-785. 4. McNally, AK. et al. 2011. Exp. Mol. Pathol. 91: 673-681. |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies